Organogenesis Holdings Inc. Class A Stock News

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit hit 52-week highs March 5.) * Arcus Biosciences Inc (NYSE: RCUS) * Arcturu

It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also...

Organogenesis (NASDAQ:ORGO) will release its earnings data after the market closes on Monday, March 9th. Analysts expect Organogenesis to post earnings of ($0.10) per share for the quarter. Persons th

Puraply is a key growth driver of Organogenesis’ advanced wound care business. There are multiple short-term, mid-term, and long-term growth catalysts for the c

Organogenesis (NASDAQ:ORGO) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday, Zacks.com repor

CANTON, Mass., Feb. 21, 2020 -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and.

CANTON, Mass., Feb. 21, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the...

It's easy to match the overall market return by buying an index fund. While individual stocks can be big winners...

Catalent Inc (NYSE: CTLT ), a contract development and manufacturing organization, or CDMO, that provides services for the development of drugs, biologics, gene therapies and consumer health products,

Organogenesis Holdings Inc (NASDAQ:ORGO) was the target of a significant drop in short interest in the month of January. As of January 15th, there was short interest totalling 76,300 shares, a drop of

So far, this January isn’t behaving as expected.

So far, this January isn’t running true to form. The market has risen, but small stocks are lagging and last year’s losers are getting hammered again Continue reading...

Organogenesis Holdings Inc. (ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical

CANTON, Mass., Jan. 23, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the...

Svb Leerink started coverage on shares of Organogenesis (NASDAQ:ORGO) in a research note issued to investors on Friday morning, BenzingaRatingsTable reports. The firm issued an outperform rating and a